Digital technologies can help older adults maintain independence and assist with their care. But resistance to change and a shortage of objective data to help communicate its value, is making it hard to commercialise products and build markets, says Martijn Vastenburg
As life sciences investors shy away from drug development and opt for lower-risk devices and diagnostics, what can Europe learn from Israel’s experience?
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.